The present invention provides a
recombinant vaccinia virus that simultaneously expresses the
extracellular segment of the S
gene of the new
coronavirus and the full-length segment of the N
gene. The present invention also provides an immunization kit containing the
recombinant vaccinia virus, and
a DNA vector expressing the
extracellular segment of the S
gene of the new
coronavirus and
a DNA vector expressing the full-length segment of the N gene of the new
coronavirus as a composite vaccine. By using the three vaccines in the composite vaccine provided by the present invention, the sequential
inoculation at 0, 2, and 4 weeks can induce experimental animals to produce CD4, CD8
cell responses specific to the N, S1, and S2 proteins of the new coronavirus, and the CD8
T cell response is higher than the CD4
T cell response, the induced
T cell immunity can last for at least 3 months, and the binding
antibody lasts for 6 months without a significant decrease, indicating that the composite vaccine can induce a lasting immune response to SARS-CoV-2, and the neutralizing antibodies induced by the vaccine have cross-reactive activity, which can prevent infection of multiple variants of the new coronavirus to a certain extent.